BPG is committed to discovery and dissemination of knowledge
Editorial Board
Professor Jian Zhang, male, born in 1978, MD, postdoctoral fellow in imaging and nuclear medicine. Executive Dean of Shanghai Universal Medical Imaging Diagnostic Center; Head of Shanghai Xuhui Enterprise Technology Center. In the past three years, more than 10 new technologies and new projects for imaging examination and diagnosis have been carried out. Among them, the early dynamics of PET for moyamoya disease + metabolic integration scan, the relationship between fistula cyst and cauda equina have filled the domestic gap. Four techniques, such as plexus nerve MRN scanning, post-processing technology and three-dimensional integrated imaging of the liver, fill the gaps in the region, provide intuitive and accurate image information for the pre-treatment evaluation of the disease and the development of the surgical plan, and benefit more than 10000 patients , which achieved good social benefits. Social Responsibility: Executive Director of Shanghai Social Medical Institutions Association; Director of China Medical Imaging AI Innovation Alliance; Director of China Non-Public Medical Institutions Association; Secretary General of Nuclear Medicine and Molecular Imaging Committee of China Non-Public Medical Institutions Association; Member of the Radiological Committee of the Chinese Medical Doctor Association. Member of the China Nuclear Medical Equipment and Technology Innovation Committee; Vice President of the Xuhui Hongmei Red Cross Society. In the past five years, he has published more than 100 papers in SCI and core journals, including more than 40 first/communication authors; 6 books and participated in the editorialoard of Chinese PET/CT Clinical Application Guideline. He hosted and participated in 6 national and provincial research projects. In December 2017, he won the second prize of the Army Science and Technology Progress Award (second finisher), which is the highest award in the domestic nuclear medicine profession. He served as Oncology Letters reviewer from March 1, 2018 and editorial board of Chinese Journal of Nuclear Medicine and Molecular Imaging.